This roundtable aired on February 20, 2024.
CPE Credit(s): 2
The Department of Justice (DOJ) has announced a series of policy changes intended to incentivize companies to voluntarily come forward with evidence of potential misconduct. The changes are meant to demonstrate to businesses the value of investing in compliance, the agency has said, but skepticism remains among companies nervous of letting a regulator in the door.
Compliance Week will host a virtual roundtable during which experts will break down the changes at the DOJ and what they mean for corporate compliance programs. Topics discussed will include new voluntary self-disclosure guidance, the agency’s corporate clawback pilot, chief compliance officer certifications, and the implications of the DOJ’s overall emphasis on improving its economic crime enforcement capabilities.
The event is scheduled to take place over the course of two hours in the following format:
- Hour 1: A Q&A with Daniel Kahn, partner at Davis Polk and former head of the DOJ’s Fraud Section and Foreign Corrupt Practices Act Unit.
- Hour 2: A roundtable discussion featuring Kyle Brasseur, editor in chief at Compliance Week; Jakub Ficner, director of partnerships at Case IQ; and Steve Naughton, director of regulatory compliance studies and clinical professor at Loyola University Chicago Law School and former CECO at PepsiCo and Kimberly-Clark, on how compliance officers should react to the DOJ’s policy changes.
Audience participants will have the chance for their questions to be answered during the event.
Learning objectives:
- Understand recent corporate enforcement changes at the DOJ
- Learn from the latest enforcement cases regarding the early impact of the DOJ’s policy changes
- Hear from experts on how compliance practitioners should be reacting to the policy changes
Speakers:
Moderator: Kyle Brasseur, Editor In Chief, Compliance Week
Jakub Ficner, Director of Partnerships, Case IQ
Daniel Kahn, Partner, White Collar Defense and Investigations, Davis Polk
Steve Naughton, Director of Regulatory Compliance Studies and Clinical Professor, Loyola University Chicago Law School
No comments yet